Sponsored Content
Japan's Rohto Pharmaceutical Invests in Austrian Sigmapharm
In a move to enhance pharmaceutical production in Europe, Japan’s Rohto Pharmaceutical has entered into a strategic partnership with the Austrian Sigmapharm Group. The collaboration aims to expand the production and distribution of ophthalmic drugs and medical products across Europe, with Rohto Pharmaceutical investing nearly €30 million in research, development, production, and sales.
The signing ceremony was attended by various officials including Florian Frauscher, Leonhard Schneemann, Masaya Saito, Ryuta Mizuuchi, and Bernhard Wittmann (f.l.t.r.). / Picture: © Bernhard Steiner
As part of this partnership, Rohto Pharmaceutical will acquire 51% of the parent company of the Sigmapharm Group, strengthening its presence in the European market while enhancing Sigmapharm’s production capacity and distribution network. Bernhard Wittmann, CEO of Sigmapharm, expressed his excitement: “Celebrating such a milestone in our 75th anniversary year is a great honor. This…
or Log In
Fast News Search